Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
Amid the satellites, virtual reality headsets, 3D printers and other hi-tech products on show at Skolkovo’s recent Startup Bazaar, the stand housing a cage of buzzing flies and jar of writhing maggots stood out. Also on the table were jars of dried and...
From its beginning, one of Skoltech’s guiding principles was to interface with industrial commercialization and venture opportunities as they develop at Skolkovo and elsewhere. This week Skoltech has realized this principle, as it has signed its first...
Prime Minister Dmitry Medvedev says Skolkovo is starting to produce tangible results, despite being less than five years old. From left: Skolkovo president Victor Vekselberg, his advisor Pekka Viljakainen, and Prime Minister Medvedev. Photo: sk.ru ...
A new 3D face recognition system developed by Skolkovo IT cluster resident Vocord FaceControl has proved flawless in testing, the company says. The biometric face recognitions system Vocord FaceControl 3D is built upon 3D machine vision, and during testing...
Russian-Finnish collaborative research that scientists hope could usher in a new age of consumer electronics took a first tentative step this month, as Skoltech students traveled to Helsinki to study nanomaterials. Photo: skoltech.ru The joint initiative...
A 30 million ruble grant from the Skolkovo Foundation is helping a team of Russian scientists develop potentially one of the most effective drugs yet to fight cardiovascular disease – the primary cause of death in Russia and the wider world. Dmitry...